Originating laboratory definition

Originating laboratory means a National Influenza Centre or other authorized laboratory that initially sends [PIP biological materials] / [clinical specimens] to other laboratories within the [WHO Network] and to other recipients.
Originating laboratory means the laboratory where the [PIP biological materials] / [clinical specimens] were first collected[, obtained and/or developed].
Originating laboratory. A National Influenza Centre or other authorized laboratory that initially sends PIP biological materials/clinical specimens to other laboratories within the WHO GISRS and to other recipients. (See PIP Framework Section 4.4). xxxx://xxxxxxxxx.xxx.xxx/publications/2011/9789241503082_eng.pdf)

Examples of Originating laboratory in a sentence

  • Originating laboratory would generally considered the data provider, but if a publicly accessible database transferred IVPP GSD to the INSDC (which might be considered a public domain data warehouse), then a publicly accessibly database like GISAID could be considered a data provider.

  • Originating laboratory can send an aliquot of all confirmed HIV positive samples to the state PHL2.

  • Originating laboratory requests, (referred to as Lab ServiceOrder in the Figure), are first checked against a Catalogue of Laboratory Investigations (process P1).


More Definitions of Originating laboratory

Originating laboratory. A National Influenza Centre or other authorized laboratory that initially sends PIP biological materials/clinical specimens to other laboratories within the WHO GISRS and to other recipients. (See PIP Framework Section 4.4). xxxx://xxxxxxxxx.xxx.xxx/publications/2011/9789241503082_eng.pdf) ORIGINATING MEMBER STATE: The Member State where the PIP biological materials/clinical specimens were first collected. (See PIP Framework Sec. 4.4). xxxx://xxxxxxxxx.xxx.xxx/publications/2011/9789241503082_eng.pdf) PANDEMIC INFLUENZA PREPAREDNESS BIOLOGICAL MATERIALS OR PIP BIOLOGICAL MATERIALS (PIP BIOLOGICAL MATERIAL) defined in the PIP Framework, Section 4 “includes human clinical specimens, virus isolates of wild type human H5N1 and other influenza viruses with human pandemic potential; and modified viruses prepared from H5N1 and/or other influenza viruses with human pandemic potential developed by WHO GISRS laboratories, these being candidate vaccine viruses generated by reverse genetics and/or high growth re-assortment. Also included in “PIP biological materials” are RNA extracted from wild-type H5N1 and other human influenza viruses with human pandemic potential and cDNA that encompass the entire coding region of one or more viral genes. xxxx://xxxxxxxxx.xxx.xxx/publications/2011/9789241503082_eng.pdf).

Related to Originating laboratory

  • Testing laboratory means a laboratory, facility, or entity in the state that offers or performs tests of cannabis or cannabis products and that is both of the following:

  • Independent testing laboratory means an independent organization, accepted by the Contracting Officer, engaged to perform specific inspections or tests of the work, either at the site or elsewhere, and report the results of these inspections or tests.

  • Approved laboratory means a laboratory that is listed in the national conference of interstate milk shipments list of sanitation compliance and enforcement ratings distributed by the United States food and drug administration and as approved by the director.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Laboratory or “LANL” means the geographical location of Los Alamos National Laboratory, a federally funded research and development center owned by the DOE / NNSA.

  • Non-Participating Clinical Laboratory means a Clinical Laboratory which does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan provide services to you at the time services are rendered.

  • Certified laboratory means a laboratory that is on an approved list issued by us.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Dental laboratory means a person, firm or corporation

  • Rural health clinic means a rural health clinic as defined under section 1861 of part C of title XVIII of the social security act, chapter 531, 49 Stat. 620, 42 U.S.C. 1395x, and certified to participate in medicaid and medicare.

  • veterinary clinic means a building where animals are given medication or surgical treatment and are cared for during the time of such treatment for financial gain;

  • Manufacturing Know-How means, with respect to the Product or any Variant thereof, the technology, data, designs, processes, methods, specifications and other know-how used in connection with the formulation, manufacture, labeling, packaging, quality control, release testing, and production of the Product, and all ingredients used therein and portions thereof.

  • Independent educational evaluation means an evaluation conducted by a qualified examiner who is not employed by the public agency responsible for the education of the child in question.

  • Forensic analysis means the practice of gathering, retaining, and analyzing computer-related data for investigative purposes in a manner that maintains the integrity of the data.

  • Radiopharmaceutical quality assurance means, but is not limited to, the performance of appropriate chemical, biological, and physical tests on potential radiopharmaceuticals and the interpretation of the resulting data to determine their suitability for use in humans and animals, including internal test assessment, authentication of product history, and the keeping of proper records.

  • Good Laboratory Practice or “GLP” means the applicable then-current standards for laboratory activities for pharmaceuticals (including biologicals) or vaccines, as applicable, as set forth in the Act and any regulations or guidance documents promulgated thereunder, as amended from time to time, together with any similar standards of good laboratory practice as are required by any Regulatory Authority having jurisdiction over the applicable activity.

  • Good Laboratory Practices or “GLP” means the then-current good laboratory practice standards promulgated or endorsed by the FDA, as defined in U.S. 21 C.F.R. Part 58 (or such other comparable regulatory standards in jurisdictions outside the United States, as they may be updated from time to time).

  • Analytical x-ray system means a group of components utilizing x-rays to determine the elemental composition or to examine the microstructure of materials.

  • Quality Surveillance Engineer / Inspector means any person appointed by or on behalf of the Purchaser to inspect or carry out quality surveillance on supplies, stores or work under the Contract or any person deputed by the Quality Surveillance Engineer for the said purpose.

  • Medical cannabis card means the same as that term is defined in Section 26-61a-102.

  • Investigational Medicinal Product means the study drug or control material as defined in the Protocol.

  • Pharmaceutical care means the provision of drug therapy and

  • Collaborating physician means the physician who,

  • Investigational Product means the Study Drug identified above and the control material, as further detailed in the Protocol;

  • hit means the existence of a match or matches established by the Central System by comparison between biometric […] data recorded in the computerised central database and those transmitted by a Member State with regard to a person, without prejudice to the requirement that Member States shall immediately check the results of the comparison pursuant to Article 26(4);